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Introduction
Breathing control is a therapeutic technique commonly 
used in physiotherapy practice to manage breathlessness. 
This technique is also known as relaxed basal breathing, 
diaphragmatic breathing, and abdominal breathing. 
Breathing control is defined as tidal breathing using the 
lower chest with relaxation of the upper chest and shoulders 
(Pryor et al 2002). During breathing control, the patient 
is encouraged to predominantly move the abdominal wall 
during inspiration while simultaneously reducing upper rib 
cage motion and accessory muscle use (Gosselink 2004).
The reported therapeutic goals of breathing control include 
correcting abnormal chest motion, reducing the work 
of breathing and sensation of dyspnoea, improving the 
efficiency of breathing, and altering the distribution of 
ventilation (Miller 1954, Cahalin et al 2002). A variety of 
mechanisms have been suggested as the means by which 
breathing control achieves these goals. The simplest of these 
proposes that increases in tidal volume result in a reduction 
in respiratory rate (Tucker and Jenkins 1996, Cahalin et al 
2002). In people with chronic obstructive pulmonary disease 
(COPD), Gosselink (2004) proposed that breathing exercises 
sought to relieve dyspnoea by increasing the strength 
and endurance of the respiratory muscles, optimising the 
thoracoabdominal respiratory pattern and reducing dynamic 
hyperinflation of the rib cage, and ultimately improving gas 
exchange. Breathing control has also been advocated as a 
technique to improve excursion of the diaphragm (Blaney 
and Sawyer 1997) and thus potentially alter the distribution 
of ventilation and lung volumes following abdominal 
surgery. Previous literature regarding breathing control has 
raised questions about the effect of the technique (Cahalin et 
al 2002). A number of authors report improvements in tidal 
volume and respiratory rate with breathing control (Miller 
1954, Sackner et al 1974, Sackner et al 1984a) while other 
studies have reported detrimental effects (Gosselink et al 
1995, Vitacca et al 1998).
The difficulty in determining which outcomes should be 
considered in reviewing the literature associated with a 
technique such as breathing control stems from the ambiguity 
surrounding procedural, physiological, and clinical 
outcomes. Clinically, a therapist-guided change in breathing 
is thought to alter respiratory mechanics and associated 
physiology, leading to a beneficial effect on symptoms. It 
is likely that studies investigating the effect of interventions 
such as breathing control report specific outcomes at one 
or more points in this sequence. For this review the effect 
of breathing control was examined for outcomes related to 
the target and mechanism of the intervention, as well as for 
physiological and clinical outcomes (Figure 1).
To date, reviews of the literature concerning breathing 
control have based their conclusions on findings presented 
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Box 1: LOW* critical appraisal tool.
1. Did the study address a clearly focused issue?
• the population studied
• the intervention / outcome studied
• whether the study tried to detect a beneficial or harmful effect
 
Yes
 No
 Can’t tell
2. Were the participants recruited in an acceptable way?
• Were the eligibility criteria clearly specified so that the participant recruitment could be repeated?
• Were the participants representative of a defined population?
•  How likely was the recruitment process to introduce bias? (participants likely to respond positively 
or negatively to intervention)
 Yes
 No
 Can’t tell
3. Was there a sufficient number of participants selected?
• Was there a power calculation?
• Did the authors provide any justification for the sample size?
Yes
 No
 Can’t tell
4. Was there a separate control group?
 
Yes (go to 5)
 No (go to 6)
5. Separate control group:
• Was there equal chance of participants being allocated to either group?
•  Were the controls representative of the intervention group (similar age, gender and variables other 
then the variable of interest)?
•  Were the eligibility criteria clearly specified so that the recruitment of the controls could be 
repeated?
• Was there a sufficient number of controls selected?
Go to 7
 
Yes
 No
 Can’t tell
6. Baseline measures for participants acting as their own controls:
Where appropriate:
•  Was the baseline stable (how confident are you that the pre measures were stable, was there a 
run-in period?)
• Was the order of interventions randomised?
• Was the washout period between intervention/control acceptable?
 
Yes
 No
 Can’t tell
7. Were the outcomes measured accurately to minimise bias?
•  Are there references to support the use of outcome measures? (details, reliability and validity of 
measures)
• Were the measurement methods similar / the same in participants and controls?
 
Yes
 No
 Can’t tell
8. Have the confounding factors been accounted for?
• Do the authors state potential confounding variables?
• Do the authors discuss and refute the impact of potential confounding variables?
•  Have the authors taken account of the potential confounding factors in the design, results and / or 
in the analyses?
Yes
 No
 Can’t tell
9. Results
a. Were the results presented so the effect size was shown or could be calculated?
• Are mean / SD (or the raw data) available to allow calculation of effect size
• Size of the p value
• Size of the confidence intervals
• Are data for participant attrition /withdrawal presented?
b. Do you subjectively believe the results?
• NOT do you accept the results?
• What are the bottom line results?
• Was the analysis appropriate to the design?
 
Yes
 No
 Can’t tell
 
Yes
 No
 Can’t tell
Final score  / 9
*LOW = Lewis, Olds, Williams. Yes = 1, No = 0, Can’t tell = 0
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in previous narrative reviews, descriptive papers, and 
uncontrolled experimental studies. Conventionally, 
systematic reviews of effect pose a ‘population-intervention-
comparator-outcome (PICO)’ question, which specifies 
and limits the context of the evidence. This systematic 
review sought to globally review all primary data from 
experimental studies of breathing control prospectively in 
order to assess the body of evidence for the intervention. A 
modified body of evidence matrix proposed by the National 
Health and Medical Research Council (2005) was used to 
assess and summarise the volume, quality, effectiveness, and 
consistency of the evidence underpinning breathing control. 
The primary questions of this systematic review were:
1.  What is the volume, quality, consistency, and 
generalisability of the evidence for breathing control?
2.  What is the effect on outcomes related to the target 
and mechanism of breathing control as well as on 
physiological and clinical outcomes?
Method
Identification and selection of studies
Searches were conducted of AMED (1985 to October 2006), 
CINAHL (1982 to October week 1 2006), MEDLINE (1966 
to September week 4 2006), Scopus (to October 2006), 
Web of Science (all citation databases 1993 to 2006) and 
the Cochrane Library (all of the Cochrane Library). The 
search strategy (Appendix 1, see eAddenda) included all 
commonly used terms for the intervention of breathing 
control and a reference to the type of therapy. Titles and 
abstracts (where available) were displayed and screened to 
identify relevant studies. Full paper copies of studies were 
obtained and their reference lists screened. The reference 
lists of any additional studies were searched again manually 
to ensure completeness. Researchers involved in the area 
were contacted for additional studies.
Initially citations were identified which indicated explicitly 
that at least one treatment group had received the sole 
intervention of breathing control (or appropriate alternative 
terms) within the title or abstract. One reviewer (LL) screened 
the initial search results for potentially eligible studies, and 
two reviewers (LL, MW) independently reviewed these 
search results for eligibility. The investigators resolved 
disagreements by consensus. All identified studies were 
then retrieved in full, as were any studies where the abstract 
was unavailable or where ambiguity existed. To be included 
in the review, studies were required to use an experimental 
design, report primary original data concerning the 
therapeutic technique of breathing control, and be published 
in English. There were no publication year limits.
Description of studies
Quality and volume of evidence: Study quality was assessed 
using a custom-made tool (Box 1). The presence or absence of 
nine methodological criteria was assessed by two independent 
reviewers (LL, MW) with a maximum possible score of 
nine. Criteria were assessed using only the documentation 
provided in the publication. Disagreements were resolved 
by a third independent reviewer (TO). Following critical 
appraisal, two reviewers then independently allocated each 
study to a level of evidence using the hierarchy proposed by 
Lloyd-Smith (1997) (Box 2).
Generalisability of evidence: Studies including people 
with chronic respiratory conditions where breathlessness 
was likely to be a feature were considered to represent the 
population where breathing control is commonly indicated. 
Generalisability of the body of evidence for breathing 
control was determined by calculating the percentage of 
studies that included participants with chronic respiratory 
diseases. The generalisability was classified as good if 75% 
of the studies included participants with chronic pulmonary 
conditions, fair (50–75%), and poor (< 50%).
Participants: There were no restrictions placed upon the 
age range of participants (children or adults) or symptoms 
(asymptomatic and participants with acute or chronic 
medical, surgical or traumatic conditions). Animal studies 
were excluded.
Intervention: Breathing control was required to be the sole 
intervention rather than performed in conjunction with other 
therapeutic techniques. Possible comparisons included 
breathing control with a control or another intervention.
Outcome measures: All outcomes were recorded.
Data analysis
The relevant details were extracted from the included 
studies by two reviewers (LL and MW). Information about 
the method (design, participants, intervention, outcome 
measures) and results (sample size, means and standard 
deviations) were extracted. Data for all outcome measures 
reported by authors or subsequently calculated by the 
reviewers from published data were extracted.
Outcome measures which used continuous scales of 
measurement (interval, ratio) only were included within this 
review. Data were entered into the Cochrane Collaboration’s 
Review Manager Software(a) to enable calculation of pooled 
estimates of the effect of breathing control using a fixed 
effects model.
Where studies reported similar domains of measurement but 
used different measurement instruments (eg, breathlessness 
measured by Borg’s perceived rate of exertion scale, or 
visual analogue scale for breathlessness), data were grouped 
via domain to permit calculation of pooled estimates. The 
overall effect of the intervention for each outcome was 
reported as SMD (95% CI) since different metrics were 
used for some outcome variables. Heterogeneity of studies 
was determined for each outcome measure using the chi-
squared statistic. Where significant heterogeneity existed 
(p < 0.05), studies and data were reviewed by the research 
team in order to identify possible sources of variation.
Results
Identification and selection of studies
Fifty-seven studies were retrieved from the search. No 
extra studies were identified through contacting experts in 
the cardiorespiratory physiotherapy field. Twenty studies 
met the inclusion criteria (see Table 1 on the eAddenda for 
details of the studies). All of these studies were published 
in full with publication dates ranging from 1954 to 2003. 
Among the 20 included studies, 285 participants were 
involved, with sample sizes in individual studies ranging 
from six to 33 participants.
Thirty-seven studies were excluded from the review. Of 
these, 18 were narrative reviews, three were descriptive 
papers, three were letters, two were guidelines, one was a 
case report, and one a consensus statement. Four studies 
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were excluded because breathing control was performed 
in conjunction with other interventions. Five studies were 
experimental in design but reported insufficient data to 
enable the calculation of means and standard deviations, 
and subsequently allow for meta-analysis (Cole et al 1962, 
Hughes 1979, Sackner et al 1984b, Girodo et al 1992, Bell 
and Saltikov 2000).
Description of studies
Volume and quality of evidence: The volume of the evidence 
was assessed using the Lloyd-Smith (1997) hierarchy of 
evidence ranking system (Box 2). No studies fulfilled the 
criterion for the highest level of evidence (1a). Two studies 
were classified as Level 1b (McNeill and McKenzie 1955, 
Wiens et al 1999) and three as Level 2a (Sackner et al 1974, 
Brach et al 1977, Sackner et al 1984a). The remaining 15 
studies were classified as Level 2b.
Methodological quality of the studies ranged from 3 
(Campbell and Friend 1955) to 8 points (Blaney and Sawyer 
1997, Wiens et al 1999, Jones et al 2003) as shown in Table 
2 (note: a maximum score of nine was possible only for 
studies with a separate control group). The most common 
methodological issues were failure to report eligibility 
criteria so that participant recruitment could be repeated 
(14 studies), failure to justify sample size (18 studies), 
absence of a separate control group (15 studies), and of the 
five studies that did have a separate control group only one 
provided suitable justification for participant allocation to 
that group (Wiens et al 1999). Ten of the 15 studies without 
a separate control group did not report whether the order 
of interventions was randomised or provide information 
regarding duration of the washout period or stability of 
baseline measures.
Generalisability of evidence: Eighty per cent of the included 
studies included participants with chronic respiratory 
conditions likely to feature breathlessness. Of these studies, 
56% (n = 9) recruited participants with COPD of severe or 
moderate severity. The remaining 20% of studies included 
participants with conditions that were not likely to feature 
breathlessness. Two of these studies recruited people 
following surgery (cholecystectomy, upper abdominal 
surgery), one recruited people asymptomatic for respiratory 
conditions, and one recruited people with chronic progressive 
multiple sclerosis. Therefore the generalisability was 
classified as good, with 80% of the included studies carried 
out on chronic respiratory conditions (emphysema, COPD, 
asthma, bronchitis, bronchiectasis, pulmonary fibrosis) 
(see Table 1 on the eAddenda).
Participants: Of the nine studies that investigated breathing 
control in people with COPD, seven reported disease 
severity as a percentage of the forced expiratory volume 
in one second (FEV1) in accordance with The American 
Thoracic Society COPD severity classification (2004): mild 
≥ 80, moderate 50–80, severe 30–50, very severe < 30. The 
severity of COPD in participants in five of the studies was 
classified as severe (Willeput et al 1983, Gosselink et al 
1995, Vitacca et al 1998, Ito et al 1999, Jones et al 2003), 
and in two studies as moderate (Grimby et al 1975, Sackner 
et al 1984a).
Intervention: Eight of the included studies investigated the 
impact of breathing control programs with training durations 
ranging between three and 12 weeks (Becklake et al 1954, 
Miller 1954, Campbell and Friend 1955, McNeill and 
McKenzie 1955, McKinley et al 1961, Williams et al 1982, 
Gosselink et al 1995, Wiens et al 1999). The remaining 12 
studies investigated breathing control compared with natural 
or spontaneous breathing (See Table 1 on the eAddenda).
Outcome measures: A total of 20 outcome measures 
provided sufficient data to permit meta-analysis. The most 
commonly reported outcomes were respiratory rate (n 
= 10), tidal volume (n = 10), and ventilation (n = 8). The 
results have been grouped according to whether outcome 
measures reflect key targets or mechanisms (short and long 
term) of breathing control, or physiological (energy cost/gas 
exchange) and clinical outcomes (reduce breathlessness). 
Effect estimates are summarised in Figure 1 and Table 3 
(see eAddenda for Table 3).
Effect on outcomes related to the target of 
intervention
Abdominal excursion: One study reported the impact of 
breathing control on abdominal excursion (Sackner et al 
1974) in 11 participants with chronic respiratory disease. 
Breathing control resulted in a significant increase in 
abdominal excursion when compared with natural breathing 
(SMD 1.36, 95% CI 0.42 to 2.31).
Diaphragm excursion: Four studies involving 72 
participants reported diaphragm excursion during the 
intervention of breathing control (Miller 1954, Sinclair 
1955, Chuter et al 1990, Blaney and Sawyer 1997). 
Breathing control resulted in a significant increase in 
diaphragm excursion (SMD 1.39, 95% CI 1.00 to 1.77) 
with the studies demonstrating significant heterogeneity 
(p < 0.0001). Two of these studies (Chuter et al 1990, 
Blaney and Sawyer 1997) were conducted on post surgical 
patients while the remaining two studies were on patients 
with chronic pulmonary disease. When considered as two 
separate groups (post surgical and chronic pulmonary 
disease) for the analyses, the studies were still shown to be 
heterogeneous (p < 0.05). This could be explained by the 
diverse patient populations, intervention type, and duration 
(short term breathing control versus prolonged training 
programs) in the different studies.
Short-term effect on outcomes related to 
mechanism of intervention
Respiratory rate: Ten studies involving 151 participants 
reported respiratory rate (Miller 1954, Campbell and Friend 
1955, Sackner et al 1974, Grimby et al 1975, Willeput et al 
1983, Sackner et al 1984a, Gosselink et al 1995, Vitacca et 
al 1998, Ito et al 1999, Jones et al 2003). The intervention 
significantly decreased respiratory rate (SMD –0.84, 95% 
CI –1.09 to –0.60). The 10 studies were significantly 
heterogeneous (p = 0.002). When one low quality (3 out 
Box 2. Hierarchy of evidence ranking system (Lloyd-Smith 
1997).
1a Meta-analysis of randomised controlled trials
1b One individual randomised controlled trial
2a One well-designed, non-randomised controlled 
study
2b Well-designed quasi-experimental study
3 Non-experimental descriptive studies – 
comparative/case studies
4 Respectable opinion
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of 9 points) study (Campbell and Friend 1955) which 
included people with emphysema of unknown severity was 
excluded from the analysis, breathing control still decreased 
respiratory rate significantly (SMD –0.75, 95% CI –1.00 to 
–0.51) and the studies were homogenous (p = 0.07).
Tidal volume: Ten studies involving 127 participants 
reported tidal volume (Miller 1954, Campbell and Friend 
1955, Sackner et al 1974, Grimby et al 1975, Brach et al 
1977, Willeput et al 1983, Sackner et al 1984a, Gosselink 
et al 1995, Vitacca et al 1998, Ito et al 1999). Breathing 
control significantly increased tidal volume (SMD 0.98, 
95% CI 0.71 to 1.25) though significant heterogeneity 
existed between studies (p = 0.0001).
Three of these studies used pre/post designs to investigate 
the impact of prolonged breathing control training (Miller 
1954, Campbell and Friend 1955, Gosselink et al 1995), 
while the remaining studies reported tidal volumes during 
the breathing control technique compared with spontaneous 
breathing. When the studies were divided into these two 
groups, breathing control significantly increased tidal 
volume following training programs (SMD 1.23, 95% CI 
0.75 to 1.70) and when compared to spontaneous breathing 
(SMD 0.86, 95% CI 0.52 to 1.19). Significant heterogeneity 
existed between studies that compared tidal volume during 
breathing control with spontaneous breathing (p = 0.0002) 
while the three studies in the post breathing control training 
group were homogenous (p = 0.06).
Four studies included participants with severe COPD, 
two studies included participants with moderate disease 
severity, and in four of the studies the severity of disease 
was not defined. When studies including people with severe 
COPD were excluded from the analysis, breathing control 
increased tidal volume significantly (SMD 0.98, 95% CI 
0.61 to 1.34) and the studies were homogenous (p = 0.09). 
Breathing control resulted in significant increases in tidal 
volume (SMD 0.98, 95% CI 0.57 to 1.39) for the four 
studies including people with severe COPD, but the studies 
demonstrated significant heterogeneity (p < 0.0001).
Ventilation: Eight studies involving 104 participants 
reported ventilation (measured in litres per minute) (Miller 
1954, Grimby et al 1975, Brach et al 1977, Willeput et al 
1983, Sackner et al 1984a, Gosselink et al 1995, Vitacca et 
al 1998, Ito et al 1999). Breathing control had no significant 
effect (SMD 0.17, 95% CI –0.11 to 0.44) and studies were 
homogenous (p = 0.05).
Long-term effect on outcomes related to 
mechanism of intervention
Vital capacity: One study involving 22 participants with 
emphysema reported the impact of breathing control 
training over a prolonged period on vital capacity (Sinclair 
1955). There was no significant effect of the intervention on 
vital capacity (SMD 0.26, 95% CI –0.33 to 0.86).
Forced vital capacity (FVC): One study involving eight 
participants with chronic obstructive bronchitis reported 
FVC (Williams et al 1982) before and after a three week 
breathing control program. No significant effect was 
calculated (SMD 0.18, 95% CI –0.80 to 1.17).
Expiratory flow rate: McNeill and McKenzie (1955) 
reported expiratory flow rate in 33 pulmonary outpatient 
participants following a four week breathing control program 
compared to a separate control group. No significant effect 
was calculated for expiratory flow rate (SMD 0.27, 95% CI 
–0.47 to 1.02).
Forced expiratory volume in one second (FEV1): One 
Table 2. Methodological quality of the 20 included studies based on the LOW critical appraisal tool.
Study LOW item
1 2 3 4 5 6 7 8 9a 9b Final score
Becklake et al 1954 yes yes yes yes yes yes 6
Blaney & Sawyer 1997 yes yes yes yes yes yes yes yes 8
Brach et al 1977 yes yes yes yes yes yes 6
Campbell & Friend 1955 yes yes yes 3
Chuter et al 1990 yes yes yes yes yes 5
Gosselink et al 1995 yes yes yes yes yes yes yes 7
Grimby et al 1975 yes yes yes yes yes 5
Ito et al 1999 yes yes yes yes yes yes yes 7
Jones et al 2003 yes yes yes yes yes yes yes yes 8
McKinley et al 1961 yes yes yes yes yes yes 6
McNeill & McKenzie 1955 yes yes yes yes yes yes 6
Miller 1954 yes yes yes yes yes 5
Sackner et al 1974 yes yes yes yes 4
Sackner et al 1984a yes yes yes yes yes yes 6
Shearer et al 1972 yes yes yes yes yes 5
Sinclair 1955 yes yes yes yes 4
Vitacca et al 1998 yes yes yes yes yes yes 6
Wiens et al 1999 yes yes yes yes yes yes yes yes 8
Williams et al 1982 yes yes yes yes yes 5
Willeput et al 1983 yes yes yes yes 4
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Figure 1. Examination of the effect (SMD, 95% CI) of breathing control on all outcomes by pooling data from all included 
trials. Effects to the right of zero favour breathing control except for respiratory rate, work of breathing, percutaneous CO2 and 
dyspnoea.
study involving eight participants with chronic obstructive 
bronchitis reported FEV1 (Williams et al 1982) before and 
after a three week breathing control program. No significant 
effect was found (SMD –0.18, 95% CI –1.16 to 0.81).
Respiratory muscle strength: Wiens et al (1999) reported 
respiratory muscle strength in 19 people with chronic 
progressive multiple sclerosis following 12 weeks 
of instruction in music therapy with an emphasis on 
diaphragmatic breathing compared to a control group. There 
was no significant effect in the intervention group compared 
with the control for either maximum inspiratory pressure 
(SMD 0.28, 95% CI –0.63 to 1.18) or maximum expiratory 
pressure (SMD 0.66, 95% CI –0.27 to 1.59).
Effect on physiological outcomes of energy cost 
and breathing
Oxygen consumption (VO2): Three studies involving 
53 participants with chronic respiratory disease reported 
oxygen consumption during and/or directly following 
Australian Journal of Physiotherapy 2007  Vol. 53  –   © Australian Physiotherapy Association 2007 225
Lewis et al: Evidence for breathing control
breathing control (Gosselink et al 1995, Ito et al 1999, Jones 
et al 2003). Breathing control had no significant effect on 
oxygen consumption across the three studies (SMD –0.17, 
95% CI –0.56 to 0.21) and the studies were homogenous (p 
= 0.14).
Work of breathing: Two studies involving 31 participants 
with chronic respiratory disease reported the impact of 
breathing control on the work of breathing measured in 
joules per litre (McKinley et al 1961, Vitacca et al 1998). 
Overall, breathing control significantly increased the work 
of breathing (SMD 1.06, 95% CI 0.52 to 1.60). Studies were 
homogenous (p = 0.11).
Respiratory muscle efficiency: One study involving seven 
participants with severe respiratory disease reported 
respiratory muscle efficiency during spontaneous breathing 
and breathing control following a three week breathing 
control program (Gosselink et al 1995). Respiratory muscle 
efficiency was determined through analysis of measures 
of minute ventilation, carbon dioxide production, oxygen 
consumption, and inspiratory and expiratory pressures 
(Gosselink et al 1995). No significant effect was found 
(SMD –0.62, 95% CI _1.70 to 0.46).
Effect on physiological outcomes of gas 
exchange
Ventilation distribution (regional clearance): Shearer et 
al (1972) reported regional clearance of nitrogen from the 
lungs in eight participants asymptomatic for respiratory 
disease. There was no significant effect of breathing control 
on regional clearance (SMD 0.41, 95% CI –0.58 to 1.41). 
Three other studies also investigated the impact of breathing 
control on regional clearance (Sackner et al 1974, Grimby et 
al 1975, Brach et al 1977) but did not report sufficient data 
to enable inclusion within the analyses. All of these studies 
reported no significant difference in regional clearance 
during the intervention of breathing control.
Arterial oxygen saturation (SaO2): Three studies involving 
55 participants with chronic respiratory disease reported 
the effect of breathing control on arterial oxygen saturation 
(Becklake et al 1954, Miller 1954, Vitacca et al 1998). 
Breathing control resulted in a significant increase in arterial 
oxygen saturation (SMD 0.63, 95% CI 0.25 to 1.02). Studies 
were homogenous (p = 0.39).
Percutaneous gases: One study involving 25 
participants with chronic respiratory disease reported 
the effect of breathing control and natural breathing on 
percutaneous oxygen and carbon dioxide (Vitacca et al 
1998). A significant increase in percutaneous oxygen 
(SMD 1.48, 95% CI 0.85 to 2.11) occurred, without a 
significant effect on percutaneous carbon dioxide (SMD 
–0.43, 95% CI –0.99 to 0.13).
Effect on clinical outcomes
Dyspnoea: Two studies involving 33 participants with 
chronic respiratory disease reported the effect of breathing 
control on dyspnoea (Williams et al 1982, Vitacca et al 
1998). Breathing control was shown to increase dyspnoea 
significantly (SMD 1.47, 95% CI 0.88 to 2.05) but studies 
were heterogeneous (p = 0.0002).
The two studies used different outcome measures to 
investigate the impact of breathing control on dyspnoea 
with Vitacca et al (1998) using a visual analogue scale and 
Williams et al (1982) the Borg Rating of Perceived Exertion 
scale. When these studies were analysed separately, 
dyspnoea increased (deteriorated) during breathing control 
(SMD 2.30, 95% CI 1.57 to 3.02) in the study by Vitacca 
et al (1998) and no significant difference was found in 
dyspnoea following a three week breathing control program 
compared with pre-training measures (SMD –0.04, 95% CI 
–1.02 to 0.94) (Williams et al 1982).
One further study by Gosselink et al (1995) measured 
dyspnoea with the modified Borg scale following a three 
week breathing control training program. Participants’ 
ratings of dyspnoea were measured both during spontaneous 
breathing and breathing control post training program. 
The study contained insufficient data to enable inclusion 
within the meta-analysis, although the authors reported a 
significant (p < 0.05) increase in dyspnoea during breathing 
control. Both of these studies (Gosselink et al 1995, 
Vitacca et al 1998) recruited people with severe pulmonary 
impairments.
12- minute Walk Test: One study involving eight participants 
with chronic respiratory disease reported the impact of a 
three week breathing control program on the distance 
achieved in the 12-minute Walk Test (Williams et al 1982). 
There was no significant effect following training (SMD 
0.07, 95% CI –0.91 to 1.05).
Discussion
Breathing control was shown to have a significant 
beneficial effect on abdominal and diaphragm excursion, 
respiratory rate, tidal volume, arterial oxygen saturation, 
and percutaneous oxygen. However, breathing control was 
shown to have a significant detrimental effect on the work 
of breathing and dyspnoea. There was no clear evidence of 
an effect on ventilation, longer-term mechanisms such as 
pulmonary volume or flow, and respiratory muscle strength. 
Additionally, there was no overall effect on physiological 
outcomes related to the energy cost of breathing such as 
oxygen consumption and respiratory muscle efficiency, or 
outcomes related to gas exchange such as the distribution of 
ventilation. Only one study investigated exercise capacity 
(12-minute Walk Test) following three weeks of breathing 
control training and this showed no significant effect.
Given the range of therapeutic goals reported by previous 
authors, it was unclear whether the corpus of studies 
investigating breathing control would assess the ultimate 
clinical endpoint of the intervention (ie, breathlessness) or 
earlier stages (mechanism or physiological outcomes) on 
the assumption that changes at this level would be likely to 
result in beneficial outcomes. In this systematic review of 
experimental studies, the impact of breathing control was 
assessed using a variety of outcome measures. When these 
outcome measures are allocated within the framework of 
outcomes related to the targets and mechanisms of breathing 
control, and physiological and clinical outcomes (Figure 1), 
the paucity of clinical outcomes becomes apparent. The 
most common outcomes investigated reflected the target 
of intervention (diaphragm and abdominal excursion) or 
mechanism of intervention (respiratory rate, tidal volume, 
and ventilation). In contrast, there was a distinct lack of 
studies reporting the impact of breathing control on clinical 
outcomes such as dyspnoea. Therefore, the majority of the 
experimental studies investigating the intervention were 
concerned with the mechanism(s) underpinning the technique 
rather than the effect of breathing control in the relief of 
breathlessness. This finding was surprising considering that 
breathing control is commonly recommended for managing 
breathlessness or dyspnoea in people with chronic respiratory 
disease (Pryor et al 2002).
This systematic review examined the effect of breathing 
control in general rather than in specific populations or 
clinical situations. Accordingly, this review included 
studies on the basis of pre-determined criteria for design, 
intervention, and comparisons, but all outcomes were 
accepted. The likelihood of missing studies was minimised 
through a comprehensive search strategy and consultation 
with experts in the field. Additionally, studies were excluded 
if they investigated breathing control in conjunction with 
other interventions such as the active cycle of breathing 
or forced expiration. Therefore the implications of this 
review may be applied only to situations where breathing 
control is applied as the sole intervention and should not 
be extrapolated to regimens which incorporate breathing 
control as part of a combined intervention.
The effect of breathing control in the included studies was 
investigated in a variety of populations. The majority of 
studies recruited people with chronic pulmonary disease 
likely to feature breathlessness. Only two studies investigated 
breathing control on post-surgical patients where it was likely 
that the intervention was targeted at altering the distribution 
of ventilation rather than at managing breathlessness.
The included studies reported the effect of breathing control 
in the short term such as in the immediate management 
of breathlessness (n = 6) and altering breathing patterns 
post surgery (n = 2). Surprisingly, the majority of studies 
included in this review investigated the long-term value of 
prolonged breathing control training of varying intensity 
and duration as a means of altering physiological outcomes 
(ie, pulmonary function). It is clear that there is no high-
level evidence to indicate a beneficial effect on lung volume 
or exercise capacity for long-term training with breathing 
control as the sole intervention in people with chronic 
respiratory disease.
The National Health and Medical Research Council (2005) 
have proposed a process and matrix to assist guideline 
developers to assess the body of evidence underpinning 
therapeutic interventions and formulate evidence-based 
recommendations. A modified version of this matrix was 
used in this review to assist in classifying the overall volume 
and consistency of the evidence for breathing control (Table 
4). The overall volume of evidence for breathing control 
was classified as satisfactory. Studies were included in this 
systemic review if they were classified as between Level 1 
and 2b on the Lloyd-Smith hierarchy. However, the majority 
of studies (75%) were classified as Level 2b. The evidence 
for breathing control was classified as inconsistent as 
indicated by the significant heterogeneity across studies in 
many of the outcomes (Table 3). These inconsistencies most 
likely result from the diversity of designs, interventions 
(short versus longer term applications), outcome variables, 
and disease severities included within the studies.
Implications for clinical practice
Despite breathing control having long been advocated as 
an intervention to manage breathlessness in people with 
chronic pulmonary disease, there was insufficient high-level 
evidence to recommend breathing control on its own as an 
effective management strategy for dyspnoea. This should 
not be interpreted as compelling evidence that breathing 
control does not alleviate breathlessness. Rather, the lack of 
experimental studies which assess clinical outcomes such as 
dyspnoea has resulted in insufficient evidence on which to 
provide a recommendation. Breathing control was found to 
have a significant short-term effect on a number of outcomes 
related to the mechanism of intervention and physiological 
outcomes (respiratory rate, tidal volume, arterial oxygen 
saturation), though no effect was evident for altering the 
distribution of ventilation or oxygen consumption. Long-term 
training of breathing control did not result in any significant 
improvement in outcomes related to the mechanism of 
intervention, or to physiological or clinical outcomes. This 
review clearly indicates that breathing control is likely to 
have a detrimental effect on dyspnoea and work of breathing 
in people with severe COPD (FEV1 %predicted 30–50). 
Based on this finding, clinicians planning to use breathing 
control as a short-term strategy to affect outcomes related to 
the mechanism of intervention or physiological outcomes 
in people with severe airflow obstruction should proceed 
cautiously and monitor dyspnoea and work of breathing.
Implications for research
This systematic review has highlighted the lack of high 
quality research concerning the therapeutic intervention of 
breathing control. The majority of studies included assessed 
outcomes related to the mechanisms underpinning breathing 
control on the assumption that changes in these would 
directly alter the sensation and sequelae of breathlessness. 
The most obvious deficiency in the evidence concerning 
breathing control is the lack of information about clinical 
outcomes specific to dyspnoea (intensity, quality of life, 
exercise capacity). The effect of breathing control in people 
with moderate or mild pulmonary impairment needs to be 
explored further. While breathing control has been advocated 
Table 4. Level of evidence for volume and consistency of studies, adapted from NHMRC (2005) and modified for the Lloyd-
Smith (1997) hierarchy of evidence.
Excellent Good Satisfactory Poor
Volume Several level 1a or 1b 
studies with a low risk 
of bias
Level 1b studies with low 
risk of bias or multiple level 
2a or 2b studies with low 
risk of bias
Level 2a or 2b studies 
with low risk of bias, or 
level 1a or 1b studies with 
moderate risk of bias
Level 3 studies, or level 
1-2 studies with high 
risk of bias
Consistency All studies consistent Most studies consistent 
and inconsistency may be 
explained
Some inconsistency 
reflecting genuine 
uncertainty around clinical 
question
Evidence is 
inconsistent
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for altering distribution of ventilation and improving lung 
volumes following surgery, few studies are available to 
support this assumption.
Footnotes: (a)RevMan 4.1.
eAddenda: Appendix 1, Table 1, and Table 3 available at 
www.physiotherapy.asn.au/AJP
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